抗载脂蛋白C1(APOC1)单克隆抗体
Anti-Apolipoprotein C1 (APOC1) Monoclonal Antibody
Apo-C1; Truncated apolipoprotein C-I
产品包装(模拟)
产品包装(模拟)
Human HepG2 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 10µg/ml mouse Anti-human APOC1 Monoclonal Antibody (Catalog FAA252Hu02, red histogram) or Isotype control antibody (Catalog IS067-Mu03, green histogram), followed by 1µg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
通过ISO 9001、ISO 13485质量体系认证
用法
For flow cytometry, the suggested use of this reagent is 0.5-2 µg per 10^6 cells in 100 µl volume.
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过一年。避免反复冻融。
赠品
增值服务
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| RPA252Hu01 | 载脂蛋白C1(APOC1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA252Hu01 | 载脂蛋白C1(APOC1)活性蛋白 | Cell culture; Activity Assays. |
| APA252Hu02 | 载脂蛋白C1(APOC1)活性蛋白 | Cell culture; Activity Assays. |
| RPA252Hu02 | 载脂蛋白C1(APOC1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA252Hu01 | 载脂蛋白C1(APOC1)多克隆抗体 | WB; IHC; ICC/IF; FCM |
| PAA252Hu02 | 载脂蛋白C1(APOC1)多克隆抗体 | WB; IHC; ICC; IP. |
| LAA252Hu71 | 载脂蛋白C1(APOC1)多克隆抗体(生物素标记) | WB; IHC; ICC. |
| MAA252Hu21 | 载脂蛋白C1(APOC1)单克隆抗体 | WB |
| MAA252Hu23 | 载脂蛋白C1(APOC1)单克隆抗体 | IHC |
| MAA252Hu22 | 载脂蛋白C1(APOC1)单克隆抗体 | WB; IHC |
| FAA252Hu02 | 抗载脂蛋白C1(APOC1)单克隆抗体 | FCM |
| FAA252Hu04 | 抗载脂蛋白C1(APOC1)单克隆抗体 | Flow cytometry. |
| SEA252Hu | 载脂蛋白C1(APOC1)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA252Hu | 载脂蛋白C1(APOC1)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
| CGA252Hu02 | 载脂蛋白C1(APOC1)cDNA | PCR、蛋白表达等 |
参考文献
| 杂志 | 参考文献 |
| PROTEOMICS - Clinical Applications | Proteomic and genomic analyses suggest the association of Apolipoprotein C1 with abdominal aortic aneurysm[Onlinelibrary: prca.201300119] |
| Journal of Dairy Science | Colostrum and milk protein rankings and ratios of importance to neonatal calf health using a proteomics approach[pubmed:28189329] |
| RESPIRATORY RESEARCH | The HDL from septic-ARDS patients with composition changes exacerbates pulmonary endothelial dysfunction and acute lung injury induced by cecal ligation …[Pubmed: 33148285] |